Trupanion, Inc. (NASDAQ:TRUP – Free Report) – Investment analysts at Northland Capmk issued their Q2 2025 earnings estimates for Trupanion in a note issued to investors on Thursday, September 19th. Northland Capmk analyst G. Gibas forecasts that the financial services provider will post earnings of $0.00 per share for the quarter. The consensus estimate for Trupanion’s current full-year earnings is ($0.37) per share. Northland Capmk also issued estimates for Trupanion’s Q3 2025 earnings at $0.02 EPS, Q4 2025 earnings at $0.03 EPS and FY2025 earnings at $0.04 EPS.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.04. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The firm had revenue of $314.80 million during the quarter, compared to analysts’ expectations of $309.33 million. During the same quarter in the previous year, the company earned ($0.33) earnings per share. The business’s revenue for the quarter was up 16.3% on a year-over-year basis.
View Our Latest Stock Analysis on Trupanion
Trupanion Price Performance
Shares of TRUP opened at $42.80 on Monday. The stock has a 50 day simple moving average of $40.56 and a 200 day simple moving average of $31.75. Trupanion has a 52-week low of $19.14 and a 52-week high of $49.14. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The firm has a market capitalization of $1.80 billion, a PE ratio of -66.88 and a beta of 1.74.
Insider Buying and Selling
In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. The disclosure for this sale can be found here. Insiders have sold a total of 8,764 shares of company stock valued at $405,238 over the last 90 days. 5.50% of the stock is owned by insiders.
Institutional Investors Weigh In On Trupanion
Several institutional investors have recently added to or reduced their stakes in TRUP. EP Wealth Advisors LLC bought a new stake in shares of Trupanion during the second quarter valued at about $294,000. AQR Capital Management LLC increased its holdings in shares of Trupanion by 173.8% in the second quarter. AQR Capital Management LLC now owns 43,553 shares of the financial services provider’s stock worth $1,280,000 after purchasing an additional 27,644 shares during the period. Marshall Wace LLP raised its position in shares of Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after buying an additional 116,496 shares in the last quarter. Public Sector Pension Investment Board boosted its stake in Trupanion by 7.3% during the second quarter. Public Sector Pension Investment Board now owns 79,555 shares of the financial services provider’s stock valued at $2,339,000 after buying an additional 5,405 shares during the period. Finally, Dalton Investments Inc. bought a new stake in Trupanion during the second quarter valued at $1,029,000.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- About the Markup Calculator
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- ESG Stocks, What Investors Should Know
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.